21566 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds Steroids, e.g. cholesterol, testosterone
METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP
#2METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS
#3METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP
#4METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS
#5NANOBIOLOGIC COMPOSITIONS FOR INHIBITING TRAINED IMMUNITY
#6Methods of treating advanced prostate cancer
#7Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation
#8Composition for cross talk between estrogen receptors and cannabinoid receptors
#9ANTIBODY CONJUGATE FOR TREATING AND DETECTING BLADDER CANCER
#10TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#11Methods of treating advanced prostate cancer
#12CATIONIC STEROID ANTIMICROBIAL DIAGNOSTIC, DETECTION, SCREENING AND IMAGING METHODS
#13Synthesis of a radioactive agent composition
#14TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#15Copper catalyzed [18F]fluorination of iodonium salts
#16Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation
#17Radiolabeled cationic steroid antimicrobials and diagnostic methods
#18Versatile and functionalised intermediates for the synthesis of vitamin D and novel vitamin D derivatives
#19LOW-DENSITY LIPOPROTEIN ANALOGUE NANOPARTICLES, AND COMPOSITION COMPRISING SAME FOR TARGETED DIAGNOSIS AND TREATMENT OF LIVER
#20RECEPTOR BINDING CONJUGATES
#21Method for synthesizing radiopharmaceuticals using a cartridge
#22COMPOUNDS FOR USE AS POSITRON EMISSION IMAGING AGENTS
#23RADIOLABELED BILE ACIDS AND BILE ACID DERIVATIVES
#2418F-labeled precursor of PET radioactive medical supplies, and preparation method thereof
#25Oral transmucosal drug delivery system
#26(11beta, 17alpha)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
#27Desmosterol-producing yeast strains and uses thereof
#28TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#29Linkers For Radiopharmaceutical Compounds
#30Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
#31BIODEGRADABLE COMPOSITE FOR INTERNAL LOCAL RADIOTHERAPY
#32Cholesterol-producing yeast strains and uses thereof
#33Multi-subunit biological complexes for treatment of plaque-associated diseases
#34Compositions for targeted imaging and therapy
#35Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
#36Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
#37Process for the preparation of radioactive labeled estradiol
#38Methods for measuring cholesterol metabolism and transport
#39Linkers for radiopharmaceutical compounds
#40Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
#41Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
#42Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use
#43Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer